• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非转移性结直肠癌中肿瘤特异性高活性低分子量细胞周期蛋白E亚型的检测与表征

Tumor-specific hyperactive low-molecular-weight cyclin E isoforms detection and characterization in non-metastatic colorectal tumors.

作者信息

Corin Irina, Di Giacomo Marilena C, Lastella Patrizia, Bagnulo Rosanna, Guanti Ginevra, Simone Cristiano

机构信息

Department of Oncology, Sahlgrenska Hospital, Gothenburg University, Gothenburg, Sweden.

出版信息

Cancer Biol Ther. 2006 Feb;5(2):198-203. doi: 10.4161/cbt.5.2.2356. Epub 2006 Feb 28.

DOI:10.4161/cbt.5.2.2356
PMID:16397408
Abstract

PURPOSE

Several molecules involved in cancer biology have been studied as potential prognostic markers. Recently, overexpression of cyclin E and its low-molecular-weight (LMW) isoforms has been reported to be the most prominent prognostic marker in breast cancer, surpassing proliferation index, ploidy, and axillary nodal involvement. Furthermore, cyclin E and p53 are considered the main factors controlling the euploid equilibrium in human cells. We investigated the status of cyclin E and p53 in cell lines and tissue samples of colorectal cancer, one of the leading causes of death from a tumor in the Western world.

EXPERIMENTAL DESIGN

We analyzed colorectal cancer cells, from established cell lines and patient specimens, to determine the protein levels of cyclin E and p53, and to detect p53 and APC mutations, microsatellite and chromosome instability. In addition, we assessed the presence of cyclin E LMW isoforms and their enzymatic activity.

RESULTS

Colorectal cancer cells expressed hyperactive LMW forms both in vitro and in vivo. These tumor-specific isoforms are correlated to genomic instability even in p53-proficient cells, and represented a constant feature in the tumors analyzed.

CONCLUSIONS

In colorectal cancer, the formation of cyclin E LMW forms is an early event leading to DNA-damage checkpoint-independent proliferation. Collectively, our results provide evidence that evaluation of LMW forms could represent a novel tool in the molecular characterization of colorectal tumors aimed at identifying sensitive prognostic factors and uncovering subsets of high-risk patients within the traditional categories.

摘要

目的

几种参与癌症生物学过程的分子已被作为潜在的预后标志物进行研究。最近,有报道称细胞周期蛋白E及其低分子量(LMW)亚型的过表达是乳腺癌中最显著的预后标志物,超过了增殖指数、倍体和腋窝淋巴结受累情况。此外,细胞周期蛋白E和p53被认为是控制人类细胞整倍体平衡的主要因素。我们研究了结直肠癌(西方世界肿瘤致死的主要原因之一)细胞系和组织样本中细胞周期蛋白E和p53的状态。

实验设计

我们分析了来自已建立的细胞系和患者标本的结肠癌细胞,以确定细胞周期蛋白E和p53的蛋白水平,并检测p53和APC突变、微卫星和染色体不稳定性。此外,我们评估了细胞周期蛋白E LMW亚型的存在及其酶活性。

结果

结肠癌细胞在体外和体内均表达高活性的LMW形式。即使在p53功能正常的细胞中,这些肿瘤特异性亚型也与基因组不稳定性相关,并且在所分析的肿瘤中是一个恒定特征。

结论

在结直肠癌中,细胞周期蛋白E LMW形式的形成是导致不依赖DNA损伤检查点的增殖的早期事件。总体而言,我们的结果提供了证据,表明对LMW形式的评估可能代表一种新工具,用于结直肠癌的分子特征分析,旨在识别敏感的预后因素并在传统分类中发现高危患者亚组。

相似文献

1
Tumor-specific hyperactive low-molecular-weight cyclin E isoforms detection and characterization in non-metastatic colorectal tumors.非转移性结直肠癌中肿瘤特异性高活性低分子量细胞周期蛋白E亚型的检测与表征
Cancer Biol Ther. 2006 Feb;5(2):198-203. doi: 10.4161/cbt.5.2.2356. Epub 2006 Feb 28.
2
Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.低分子量细胞周期蛋白E在转基因小鼠中的过表达通过破坏ARF-p53途径诱导转移性乳腺癌。
Cancer Res. 2007 Aug 1;67(15):7212-22. doi: 10.1158/0008-5472.CAN-07-0599.
3
Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.低分子量细胞周期蛋白 E 的过度表达缩短了有丝分裂,导致染色体错误分离和中心体扩增。
Cancer Res. 2010 Jun 15;70(12):5074-84. doi: 10.1158/0008-5472.CAN-09-4094. Epub 2010 Jun 8.
4
Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.细胞周期蛋白E的肿瘤特异性低分子量形式可诱导乳腺癌中的基因组不稳定以及对p21、p27和抗雌激素的抗性。
Cancer Res. 2004 May 1;64(9):3198-208. doi: 10.1158/0008-5472.can-03-3672.
5
Overexpression of Cyclin E and its Low Molecular Weight Isoforms Cooperate with Loss of p53 in Promoting Oncogenic Properties of MCF-7 Breast Cancer Cells.细胞周期蛋白E及其低分子量异构体的过表达与p53缺失协同促进MCF-7乳腺癌细胞的致癌特性。
Asian Pac J Cancer Prev. 2015;16(17):7575-82. doi: 10.7314/apjcp.2015.16.17.7575.
6
Low-molecular-weight cyclin E: the missing link between biology and clinical outcome.低分子量细胞周期蛋白E:生物学与临床结果之间缺失的环节。
Breast Cancer Res. 2004;6(5):188-91. doi: 10.1186/bcr905. Epub 2004 Jul 7.
7
Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.细胞周期蛋白E、p27和突变型p53不能预测美国癌症联合委员会(AJCC)II期结直肠癌的预后。
Korean J Gastroenterol. 2004 Dec;44(6):314-20.
8
CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.CDC4突变发生在一部分结直肠癌中,但预计不会导致功能丧失,且与染色体不稳定无关。
Cancer Res. 2005 Dec 15;65(24):11361-6. doi: 10.1158/0008-5472.CAN-05-2565.
9
Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.低分子量细胞周期蛋白E在乳腺癌中具有特异性,且与肿瘤进展机制相关。
Cell Cycle. 2009 Apr 1;8(7):1062-8. doi: 10.4161/cc.8.7.8119. Epub 2009 Apr 10.
10
A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer.研究细胞周期蛋白 E 及其同工型在早期结肠癌肿瘤和相邻黏膜中的表达,并与患者预后相关。
Acta Oncol. 2010;49(1):63-9. doi: 10.3109/02841860903268049.

引用本文的文献

1
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or Alteration.联合PARP和Wee1激酶抑制剂靶向复制应激和DNA修复在伴有细胞周期蛋白E改变的三阴性乳腺癌中具有协同作用。
Cancers (Basel). 2021 Apr 1;13(7):1656. doi: 10.3390/cancers13071656.
2
Molecular crosstalk between cancer and neurodegenerative diseases.癌症与神经退行性疾病的分子串扰。
Cell Mol Life Sci. 2020 Jul;77(14):2659-2680. doi: 10.1007/s00018-019-03428-3. Epub 2019 Dec 28.
3
Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.
低分子量细胞周期蛋白 E 在人类癌症中的作用:细胞后果及靶向治疗的机会。
Cancer Res. 2018 Oct 1;78(19):5481-5491. doi: 10.1158/0008-5472.CAN-18-1235. Epub 2018 Sep 7.
4
Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.细胞质细胞周期蛋白 E 介导乳腺癌对芳香酶抑制剂的耐药性。
Clin Cancer Res. 2017 Dec 1;23(23):7288-7300. doi: 10.1158/1078-0432.CCR-17-1544. Epub 2017 Sep 25.
5
Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.乳腺癌合并中枢神经系统转移患者的治疗策略:现状与未来前景。
Ann Oncol. 2017 Jan 1;28(1):44-56. doi: 10.1093/annonc/mdw532.
6
Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.细胞质周期蛋白E可预测乳腺癌患者的复发情况。
Clin Cancer Res. 2017 Jun 15;23(12):2991-3002. doi: 10.1158/1078-0432.CCR-16-2217. Epub 2016 Nov 23.
7
Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.细胞质细胞周期蛋白E和磷酸化细胞周期蛋白依赖性激酶2是侵袭性乳腺癌的生物标志物。
Am J Pathol. 2016 Jul;186(7):1900-1912. doi: 10.1016/j.ajpath.2016.02.024. Epub 2016 May 13.
8
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.细胞周期蛋白E与脂肪生成酶ATP-柠檬酸裂解酶结合,促进乳腺癌细胞的恶性生长。
Cancer Res. 2016 Apr 15;76(8):2406-18. doi: 10.1158/0008-5472.CAN-15-1646. Epub 2016 Feb 29.
9
Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint.缺乏FBW7肿瘤抑制因子的人结肠直肠细胞对纺锤体组装检查点的依赖性。
Genetics. 2015 Nov;201(3):885-95. doi: 10.1534/genetics.115.180653. Epub 2015 Sep 8.
10
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.一项关于细胞周期蛋白依赖性激酶(CDK)抑制剂地西他滨(SCH 727965)与表柔比星联合用于转移性三阴性乳腺癌患者的1期剂量扩展研究。
Invest New Drugs. 2015 Aug;33(4):890-4. doi: 10.1007/s10637-015-0244-4. Epub 2015 May 7.